Diabetes Therapeutics Flashcards
according to the ADA, what are the recommendations for tailoring diabetes treatment to reduce disparities?
-providers should assess social context, including potential food insecurity, housing stability, and financial barriers
-patients should be referred to local community resources when available
-patients should be provided with self-management support
according to the ADA, what are the criteria for testing in asymptomatic adults?
1. all adults ___ years or older, if normal, repeat every __ years
2. patients with prediabetes should be tested _____
3. women with history of GDM should be tested every __ years
4. testing every _____ years should be considered if BMI is over ____ (or BMI over _____ in asian americans) and at least one of the following risk factors???
35, 3
yearly
3
1-3, 25, 23,
-first-degree relative with diabetes
-women with PCOS
-hypertension
-HDL under 35 and/or TG over 250
-history of CVD
-physical inactivity
-BMI over 40
blood glucose levels used to diagnose diabetes based on fasting plasma glucose and 2-hour plasma glucose (after 75-g OGTT)?
**diagnosis of Diabetes requires what in regards to testing?
Fasting plasma glucose:
diabetes: over 126
2-hour plasma glucose (after 75-g OGTT):
diabetes: over 200
**2 Abnormal test results
define latent autoimmune diabetes (LADA)
autoimmune diabetes associated with older age (30-50 y/o), presence of islet autoantibodies, and a slower progression to insulin requirement
what are examples of disease-induced diabetes?
hyperglycemia caused by systemic infections, hyperthyroidism, pancreatitis, cushing syndrome, cystic fibrosis, and organ transplant
what are examples of drug-induced diabetes?
transplant meds and corticosteroids
define monogenic diabetes
genetic defects resulting in Beta-cell dysfunction
when do we screen for gest. diabetes in pts w/ risk factors for DM?
if no risk factors?
at first prenatal visit
24-28 weeks of gestation (third trimester)
how do we test for gest. diabetes?
what lab values confirm gest. diabetes?
1-step 75g OGTT or 2-step with 50g followed by a 3 hour 100g OGTT for those who screen positive
1-step:
Fasting over 92
1 hr over 180
2 hour over 153
2-step:
Fasting over 95
1 hr over 180
2 hr over 155
3 hr over 140
what is the C-peptide level at diagnosis for T2DM, T1DM, and LADA?
T2DM: normal to increased , can be low if late
T1DM: very low or undetectable
LADA: decreased but still detectable
Guidelines to diagnosing diabetes: Adult with suspected type 1 diabetes—
Test islet autoantibodies. if positive?
if negative, check C-peptide. what does C-peptide level tell us?
type 1 diabetes
if over 200 perform genetic testing for monogenic diabetes. if under 200 diagnose with T1 diabetes.
what did the Diabetes Prevention Program show?
lifestyle changes with intensive diet and exercise is significantly better at preventing diabetes than prescribing metformin
patients with prediabetes should be referred to?
what are the goals?
an on-going support program modeled on the diabetes prevention program
7% weight loss and at least 150 min/week of moderate activity
T/F no drug therapies are approved for diabetes prevention, but metformin may be considered
true
for starting a statin:
initiate if LDL is over?
if age 40-75 with diabetes?
190
start moderate-intensity statin and determine use of high-intensity
in a pt with ASCVD risk 5-7.5%, what risk enhancers would make you consider a moderate-intensity statin?
-family history
-LDL chronically over 160
-TG chronically over 175
-CKD
-metabolic syndrome
-preeclampsia, premature menopause
-inflammatory diseases
-ethnicity (south asian)
For diabetes care, how often should the following be assessed?
height/weight, blood pressure, lifestyle management, depression
every visit
how often should a diabetic foot exam, dilated retinal exam, and urinary albumin be performed?
at least annually
when do we prescribe aspirin for diabetics?
what about clopidogrel?
secondary prevention with a history of ASCVD, potentially primary prevention depending on pt bleeding risk
use clopidogrel 75mg for pts with ASCVD and documented aspirin allergy
what did the ASCEND trial show?
aspirin was not much more effective at preventing adverse bleeding outcomes compared to placebo
what is diabetic ketoacidosis (DKA)?
uncontrolled hyperglycemia, metabolic acidosis, and increased total body ketones
what is hyperosmolar hyperglycemic state (HHS)?
severe hyperglycemia, hyperosmolality, and dehydration w/o ketoacidosis
what are the characteristics of DKA?
-glucose over 250
-ketosis (beta-hydroxybutyrate over 3)
-acidosis (pH less than 7.3)
-bicarb/CO2 less than 18 (bodies response to decreasing pH)
-anion gap over 10-12
-positive urine or blood acetoacetate
what are the signs/symptoms of DKA?
-excessive urination
-severe thirst
-blurred vision
-signs of dehydration
-warm dry skin
-kussmaul respiration (deep breathing due to high CO2 compensation
-fruity odor breath
-progressive mental status changes
what are common causes of DKA?
what meds increase the chance of DKA?
-missed insulin doses
-infection
-new-onset DM
-clozapine, olanzapine, steroids, SGLT2-is (for T1DM)
what is the primary cause of HHS? other causes?
infection
missed med doses, MI, stroke, and trauma
signs/symptoms of HHS?
-hyperglycemia, but little acidosis
-symptom progression over days
-severe dehydration
what are characteristics of HHS? (distinguishes it from DKA)
-glucose over 600
-pH over 7.3
-bicarb/CO2 over 15
-urine or blood beta-hydroxybutyrate less than 3
-serum osmolality over 320
-anion gap under 12
-urine or blood acetoacetate negative or low positive
how do we treat hyperglycemic crises?
give fluids, potassium repletion to correct acidosis, and give insulin to correct hyperglycemia (causes decrease in potassium)